Skip to Main Content

Author Details

S??ren Buus
University of Copenhagen
1974
320
71
PMIDPaper TitleJournal TitlePublished Year
36695639High levels of antibodies 6 months after COVID-19 vaccination in children with severe chronic diseases: A prospective longitudinal case series.Acta Paediatr2023
37662376Coxsackievirus infection induces direct pancreatic β-cell killing but poor anti-viral CD8+ T-cell responses.bioRxiv2023
37483599The structure of songbird MHC class I reveals antigen binding that is flexible at the N-terminus and static at the C-terminus.Front Immunol2023
36992095Efficacy of Phase I and Phase II <i>Coxiella burnetii</i> Bacterin Vaccines in a Pregnant Ewe Challenge Model.Vaccines (Basel)2023
35042788Minimal Information about MHC Multimers (MIAMM).J Immunol2022
35453564Defective Proinsulin Handling Modulates the MHC I Bound Peptidome and Activates the Inflammasome in β-Cells.Biomedicines2022
36545256Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade.Oncoimmunology2022
36423003Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from <i>Theileria parva</i> Infected Cells.Vaccines (Basel)2022
36330531HIV specific CD8<sup>+</sup> T<sub>RM</sub>-like cells in tonsils express exhaustive signatures in the absence of natural HIV control.Front Immunol2022
36288703Focused B cell response to recurring gluten motif with implications for epitope spreading in celiac disease.Cell Rep2022
33436573Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.Nat Commun2021
33789985Integral Use of Immunopeptidomics and Immunoinformatics for the Characterization of Antigen Presentation and Rational Identification of BoLA-DR-Presented Peptides and Epitopes.J Immunol2021
34659264Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report.Front Immunol2021
34561224CD8<sup>+</sup> T Cells Variably Recognize Native Versus Citrullinated GRP78 Epitopes in Type 1 Diabetes.Diabetes2021
34835021Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain.Viruses2021
32482711HLA Class II Specificity Assessed by High-Density Peptide Microarray Interactions.J Immunol2020
37427310Immunoinformatics: Predicting Peptide-MHC Binding.Annu Rev Biomed Data Sci2020
33303011Measles-mumps-rubella vaccine at 6â¿¿months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial.Trials2020
32973802Effector CD8 T Cell-Dependent Zika Virus Control in the CNS: A Matter of Time and Numbers.Front Immunol2020
32903714Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction.Front Immunol2020
32928873Peptides Derived From Insulin Granule Proteins Are Targeted by CD8<sup>+</sup> T Cells Across MHC Class I Restrictions in Humans and NOD Mice.Diabetes2020
32983097A Systematic, Unbiased Mapping of CD8<sup>+</sup> and CD4<sup>+</sup> T Cell Epitopes in Yellow Fever Vaccinees.Front Immunol2020
32132233T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.J Virol2020
31578220NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions.Mol Cell Proteomics2019
29315598Improved methods for predicting peptide binding affinity to MHC class II molecules.Immunology2018
30078552Conventional and Neo-antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors.Cell Metab2018
30487790Major TCR Repertoire Perturbation by Immunodominant HLA-B<sup>*</sup>44:03-Restricted CMV-Specific T Cells.Front Immunol2018
30547051Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA.Mol Ther Methods Clin Dev2018
30446001Footprints of antigen processing boost MHC class II natural ligand predictions.Genome Med2018
29623081A New <i>In Vivo</i> Model to Study Protective Immunity to Zika Virus Infection in Mice With Intact Type I Interferon Signaling.Front Immunol2018
29429978Islet-reactive CD8<sup>+</sup> T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors.Sci Immunol2018
29167337Differential Immunodominance Hierarchy of CD8<sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection.J Virol2018
28886949Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs.Vaccine2017
28386132Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination.Sci Rep2017
28077675Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools.Sci Transl Med2017
28077659HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer<sup>+</sup> Gag-Specific CD4<sup>+</sup> T Cells in Chronic Clade C HIV-1 Infection.J Virol2017
28095436ArrayPitope: Automated Analysis of Amino Acid Substitutions for Peptide Microarray-Based Antibody Epitope Mapping.PLoS One2017
29435138Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes.Oncotarget2017
29232408Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations.PLoS One2017
29020090Saporin-conjugated tetramers identify efficacious anti-HIV CD8+ T-cell specificities.PLoS One2017
28878089HLA-B*14:02-Restricted Env-Specific CD8<sup>+</sup> T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection.J Virol2017
28589207Prediction and in vitro verification of potential CTL epitopes conserved among PRRSV-2 strains.Immunogenetics2017
28582449HIV-1 adaptation to NK cell-mediated immune pressure.PLoS Pathog2017
28819312Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles.Sci Rep2017
28686208Structural Elements Recognized by Abacavir-Induced T Cells.Int J Mol Sci2017
26810224Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.J Immunol2016
26572135A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.Immunogenetics2016
27498407Expanding specificity of class I restricted CD8<sup>+</sup> T cells for viral epitopes following multiple inoculations of swine with a human adenovirus vectored foot-and-mouth disease virus (FMDV) vaccine.Vet Immunol Immunopathol2016
27402703Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity.J Immunol2016
26886513Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.PLoS Negl Trop Dis2016
  • 1 - 50 of 320

Recommended Authors

La Trobe Institute for Molecular Science, La Trobe University
Career Start Year 2005
Number of shared co-authors 1
Hannover Medical School
Career Start Year 2004
Number of shared co-authors 1
Benaroya Research Institute
Career Start Year 2003
Number of shared co-authors 1
Universite Paris Saclay
Career Start Year 2002
Number of shared co-authors 0
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
University of Texas Southwestern Medical Center
Career Start Year 1998
Number of shared co-authors 3
University of California
Career Start Year 1996
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 1994
Number of shared co-authors 0
Center for Systems Immunology, Benaroya Research Institute
Career Start Year 1993
Number of shared co-authors 2
Allergy and Critical Care Medicine Emory University School of Medicine
Career Start Year 1988
Number of shared co-authors 4
Weill Cornell School of Medicine
Career Start Year 1988
Number of shared co-authors 0
University of California los angeles
Career Start Year 1988
Number of shared co-authors 0
Translational Health Science and Technology Institute
Career Start Year 1987
Number of shared co-authors 0
France French Academy of Pharmacy
Career Start Year 1983
Number of shared co-authors 4
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 2
Washington University
Career Start Year 1982
Number of shared co-authors 2
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1982
Number of shared co-authors 6
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 11
Niigata University of Health and Welfare
Career Start Year 1981
Number of shared co-authors 0
University of Texas Southwestern Medical Center
Career Start Year 1981
Number of shared co-authors 1
Biomedical Center, Lund University
Career Start Year 1979
Number of shared co-authors 1
and Blood Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 0
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 3
Lund University
Career Start Year 1977
Number of shared co-authors 2
Universite de Strasbourg
Career Start Year 1976
Number of shared co-authors 1
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 1
University of Virginia School of Medicine
Career Start Year 1976
Number of shared co-authors 5
Wash Benaroya Research Institute at Virginia Mason
Career Start Year 1975
Number of shared co-authors 7
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1971
Number of shared co-authors 1
Center for Phenomic Health, The Buck Institute for Research on Aging
Career Start Year 1961
Number of shared co-authors 2

Collaborators

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers 34
University of Washington School of Medicine
Co-authored papers 18
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers 13
Ragon Institute of Mass General
Co-authored papers 12
Co-authored papers 7
Co-authored papers 7
Frederick National Laboratory for Cancer Research, National Cancer Institute
Co-authored papers 6
Vanderbilt University Medical Center
Co-authored papers 6
PSL University, CNRS UMR9
Co-authored papers 5
University of Georgia
Co-authored papers 5
Universite PSL, LPC CNRS UMR8249
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
EpiVax Inc.
Co-authored papers 4
University of Colorado - Anschutz Medical Campus
Co-authored papers 3
University of Virginia
Co-authored papers 3
University of Virginia
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
University of Virginia
Co-authored papers 3
Co-authored papers 3
EpiVax Inc.
Co-authored papers 3
International Livestock Research Institute (ILRI)
Co-authored papers 3
Co-authored papers 3
Monash Biomedicine Discovery Institute, Monash University
Co-authored papers 2
Ecole Polytechnique Federale de Lausanne
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Center for Natural Products Research, University of Havana
Co-authored papers 2
Co-authored papers 2